Φορτώνει......
Pharmacological Management of High-risk Neuroblastoma in Children
BACKGROUND: Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Children with high-risk disease have a 3-year event-free survival rate of only 20%. Chemotherapy is the mainstay of the treatment of children with advanced neuroblastom...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Paediatr Drugs |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2011
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321778/ https://ncbi.nlm.nih.gov/pubmed/21692548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11591630-000000000-00000 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|